Home · Stock · PFE

PFE Pfizer Inc

Which ETFs hold PFE? Pfizer Inc is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 31 Aug 2026
HealthcareDrug Manufacturers - General
$27.82
+20.1% 1y
$23.6252-week range$29.21
Market cap
$158.5B
P/E
36.6
Dividend
6.18%
3-month
+17.1%
CEO
Dr. Albert Bourla D.V.M., Ph.D.
Revenue · last 4 qtrs (+2.6% YoY)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Provider

Currently Held By

VANGUARD
VOO
Weight in fund0.24%
Shares held151,423,159
Market value$4.31B
View fund →
SMARTSHARES
USF
Smart US 500 ETF
via VOO
Weight in fund0.24%
Shares held—
Market value$3.1M NZD
View fund →
Not held by the selected provider.
last 90 days
No notable insider activity in the last 90 days. Show all 7 trades
Net flow (90d):+$256K·7 BUY / 0 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
30 Sep 2026
Albert Bourla
Chairman of the Board & CEO
BUYVested (RSU)21$5990
25 Sep 2026
Mortimer J Buckley
Director / Other
BUYVested (RSU)1,308$38K30
25 Sep 2026
Joseph Echevarria
Director / Other
BUYVested (RSU)1,613$46K30
25 Sep 2026
James C Smith
Director / Other
BUYVested (RSU)1,570$45K30
25 Sep 2026
James Quincey
Director / Other
BUYVested (RSU)1,352$39K30
25 Sep 2026
Cyrus Taraporevala
Director / Other
BUYVested (RSU)1,308$38K30
25 Sep 2026
Shantanu Narayen
Director / Other
BUYVested (RSU)1,744$50K30
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
0 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
No trades recorded yet.
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds